메뉴 건너뛰기




Volumn 43, Issue 3, 2004, Pages 163-166

Immunoglobulin therapy: History, indications, and routes of administration

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

EID: 1842487488     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02236.x     Document Type: Article
Times cited : (28)

References (35)
  • 1
    • 0028304289 scopus 로고
    • Intravenous gammaglobulin: Pharmacology, clinical uses and mechanisms of action
    • Schiff RI. Intravenous gammaglobulin: Pharmacology, clinical uses and mechanisms of action. Pediatr Allergy Immunol 1994; 5: 63-87.
    • (1994) Pediatr. Allergy Immunol. , vol.5 , pp. 63-87
    • Schiff, R.I.1
  • 2
    • 0023674879 scopus 로고
    • Human gamma globulins as therapeutic agents
    • Stiehm ER. Human gamma globulins as therapeutic agents. Adv Pediatr 1988; 35: 1-72.
    • (1988) Adv. Pediatr. , vol.35 , pp. 1-72
    • Stiehm, E.R.1
  • 3
    • 33947444499 scopus 로고
    • Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids
    • Cohn EJ, Strong LE, Hughes WL Jr, et al. Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J Am Chem Soc 1946; 68: 459-475.
    • (1946) J. Am. Chem. Soc. , vol.68 , pp. 459-475
    • Cohn, E.J.1    Strong, L.E.2    Hughes Jr., W.L.3
  • 5
    • 0000635717 scopus 로고
    • Large scale production of human plasma fractions: Eight years of experience with the alcohol fractionation procedure of Nitschmann, Kistler and Lergier
    • Kistler P, Nitschmann H. Large scale production of human plasma fractions: Eight years of experience with the alcohol fractionation procedure of Nitschmann, Kistler and Lergier. Vox Sang 1962; 7: 414-424.
    • (1962) Vox. Sang. , vol.7 , pp. 414-424
    • Kistler, P.1    Nitschmann, H.2
  • 6
    • 0022540377 scopus 로고
    • Development of immunoglobulin preparations for intravenous use
    • Barandun S, Isliker H. Development of immunoglobulin preparations for intravenous use. Vox Sang 1986; 51: 157-160.
    • (1986) Vox. Sang. , vol.51 , pp. 157-160
    • Barandun, S.1    Isliker, H.2
  • 7
    • 0000419304 scopus 로고
    • Agammaglobulinemia
    • Bruton OC. Agammaglobulinemia. Pediatrics 1952; 9: 722-727.
    • (1952) Pediatrics , vol.9 , pp. 722-727
    • Bruton, O.C.1
  • 8
    • 19044377860 scopus 로고    scopus 로고
    • Intravenous immunoglobulins: Clinical experience and viral safety
    • Ballow M. Intravenous immunoglobulins: Clinical experience and viral safety. J Am Pharm Assoc 2002; 42: 449-458.
    • (2002) J. Am. Pharm. Assoc. , vol.42 , pp. 449-458
    • Ballow, M.1
  • 9
    • 0026422422 scopus 로고
    • The use of intravenous immune globulin in immunodeficiency diseases
    • Buckley RH, Schiff RI. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 1991; 325: 110-117.
    • (1991) N. Engl. J. Med. , vol.325 , pp. 110-117
    • Buckley, R.H.1    Schiff, R.I.2
  • 10
    • 0034775263 scopus 로고    scopus 로고
    • Intravenous immunoglobulin consensus statement
    • and the IVIG Advisory Panel III. Consensus reporT
    • Sacher RA, and the IVIG Advisory Panel III. Consensus reporT. Intravenous immunoglobulin consensus statement. J Allergy Clin Immunol 2001; 108: S139-S146.
    • (2001) J. Allergy Clin. Immunol. , vol.108
    • Sacher, R.A.1
  • 11
    • 0027102912 scopus 로고
    • Established and new uses of intravenous immunoglobulin
    • Cunningham-Runddles C. Established and new uses of intravenous immunoglobulin. Mt Sinai J Med 1992; 59: 335-340.
    • (1992) Mt. Sinai J. Med. , vol.59 , pp. 335-340
    • Cunningham-Runddles, C.1
  • 12
    • 0036221826 scopus 로고    scopus 로고
    • Intravenous immunoglobulin in neurological disease: A specialist review
    • Wiles CM, Brown P, Chapel H, et al. Intravenous immunoglobulin in neurological disease: A specialist review. J Neurol Neurosurg Psychiatry 2002; 72: 440-448.
    • (2002) J. Neurol. Neurosurg. Psychiatry , vol.72 , pp. 440-448
    • Wiles, C.M.1    Brown, P.2    Chapel, H.3
  • 13
    • 2442583225 scopus 로고    scopus 로고
    • Toxic epidermal necrolysis - Intravenous immunoglobulin. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: Multicenter retrospective analysis of 48 consecutive cases
    • for the TEN IVIG Study Group
    • Prins C, Kerdel FA, Padilla RS, et al., for the TEN IVIG Study Group. Toxic epidermal necrolysis - intravenous immunoglobulin. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: Multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 2003; 139: 26-32
    • (2003) Arch. Dermatol. , vol.139 , pp. 26-32
    • Prins, C.1    Kerdel, F.A.2    Padilla, R.S.3
  • 14
    • 0036715291 scopus 로고    scopus 로고
    • Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris
    • Sami N, Qureshi A, Ruocco E, Ahmed AR. Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris. Arch Dermatol 2002; 138: 1158-1162.
    • (2002) Arch. Dermatol. , vol.138 , pp. 1158-1162
    • Sami, N.1    Qureshi, A.2    Ruocco, E.3    Ahmed, A.R.4
  • 15
    • 0035185417 scopus 로고    scopus 로고
    • Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment
    • Ahmed AR. Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol 2001; 45: 825-835
    • (2001) J. Am. Acad. Dermatol. , vol.45 , pp. 825-835
    • Ahmed, A.R.1
  • 16
    • 0035064094 scopus 로고    scopus 로고
    • A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders
    • Jolles S. A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders. Clin Exp Dermatol 2001; 26: 127-131.
    • (2001) Clin. Exp. Dermatol. , vol.26 , pp. 127-131
    • Jolles, S.1
  • 17
    • 0036113782 scopus 로고    scopus 로고
    • The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases
    • Pyne D, Ehrenstein M, Morris V. The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases. Rheumatology 2002; 41: 367-374.
    • (2002) Rheumatology , vol.41 , pp. 367-374
    • Pyne, D.1    Ehrenstein, M.2    Morris, V.3
  • 18
    • 0036286074 scopus 로고    scopus 로고
    • Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency
    • Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002; 109: 1001-1004.
    • (2002) J. Allergy Clin. Immunol. , vol.109 , pp. 1001-1004
    • Busse, P.J.1    Razvi, S.2    Cunningham-Rundles, C.3
  • 19
    • 0034769492 scopus 로고    scopus 로고
    • Antibody-directed therapy: Past, present, and future
    • Gelfand EW. Antibody-directed therapy: Past, present, and future. J Allergy Clin Immunol 2001; 108: S111-S116.
    • (2001) J. Allergy Clin. Immunol. , vol.108
    • Gelfand, E.W.1
  • 20
    • 0028857579 scopus 로고
    • Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: Safety and costs
    • Gardulf A, Andersen V, Bjorkander J, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: Safety and costs. Lancet 1995; 345: 365-369.
    • (1995) Lancet , vol.345 , pp. 365-369
    • Gardulf, A.1    Andersen, V.2    Bjorkander, J.3
  • 21
    • 0018825013 scopus 로고
    • Immunoglobulin replacement therapy by slow subcutaneous infusion
    • Berger M, Cupps TR, Fauci AS. Immunoglobulin replacement therapy by slow subcutaneous infusion. Ann Intern Med 1980; 93: 55-56.
    • (1980) Ann. Intern. Med. , vol.93 , pp. 55-56
    • Berger, M.1    Cupps, T.R.2    Fauci, A.S.3
  • 22
    • 0020960844 scopus 로고
    • Slow subcutaneous immunoglobulin therapy in a patient with reactions to intramuscular immunoglobulin
    • Welch MJ, Stiehm ER. Slow subcutaneous immunoglobulin therapy in a patient with reactions to intramuscular immunoglobulin. J Clin Immunol 1983; 3: 285-286.
    • (1983) J. Clin. Immunol. , vol.3 , pp. 285-286
    • Welch, M.J.1    Stiehm, E.R.2
  • 23
    • 0020055647 scopus 로고
    • High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy
    • Berger M, Cupps TR, Fauci AS. High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy. J Am Med Assoc 1982; 247: 2824-2825
    • (1982) J. Am. Med. Assoc. , vol.247 , pp. 2824-2825
    • Berger, M.1    Cupps, T.R.2    Fauci, A.S.3
  • 24
    • 0022648987 scopus 로고
    • Subcutaneous immunoglobulin home treatment in hypogammaglobulinaemia
    • (letter)
    • Leahy MF. Subcutaneous immunoglobulin home treatment in hypogammaglobulinaemia (letter). Lancet 1986; 2: 48.
    • (1986) Lancet , vol.2 , pp. 48
    • Leahy, M.F.1
  • 25
    • 0025738608 scopus 로고
    • Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion
    • Gardulf A, Hammarstrom L, Smith CI. Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet 1991; 338: 162-166.
    • (1991) Lancet , vol.338 , pp. 162-166
    • Gardulf, A.1    Hammarstrom, L.2    Smith, C.I.3
  • 26
    • 0027180544 scopus 로고
    • The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions
    • Gardulf A, Bjorvell H, Gustafson R, et al. The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions. Clin Exp Immunol 1993; 92: 200-204.
    • (1993) Clin. Exp. Immunol. , vol.92 , pp. 200-204
    • Gardulf, A.1    Bjorvell, H.2    Gustafson, R.3
  • 27
    • 0027724615 scopus 로고
    • Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency
    • Gardulf A, Bjorvell H, Gustafson R, et al. Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency. Immunodeficiency 1993; 4: 81-84.
    • (1993) Immunodeficiency , vol.4 , pp. 81-84
    • Gardulf, A.1    Bjorvell, H.2    Gustafson, R.3
  • 28
    • 0029908505 scopus 로고    scopus 로고
    • Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies
    • Abrahamsen TG, Sandersen H, Bustnes A. Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies. Pediatrics 1996; 98: 1127-1131.
    • (1996) Pediatrics , vol.98 , pp. 1127-1131
    • Abrahamsen, T.G.1    Sandersen, H.2    Bustnes, A.3
  • 29
    • 0034073949 scopus 로고    scopus 로고
    • The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
    • Chapel HM, Spickett GP, Ericson D, et al. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol 2000; 20: 94-100.
    • (2000) J. Clin. Immunol. , vol.20 , pp. 94-100
    • Chapel, H.M.1    Spickett, G.P.2    Ericson, D.3
  • 30
    • 0036281312 scopus 로고    scopus 로고
    • Novel aspects of hypogammaglobulinemic states: Subcutaneous immunoglobulin treatment
    • Grunebaum E, Levy Y, Shoenfeld Y. Novel aspects of hypogammaglobulinemic states: Subcutaneous immunoglobulin treatment. Isr Med Assoc J 2002; 4: 288-289.
    • (2002) Isr. Med. Assoc. J. , vol.4 , pp. 288-289
    • Grunebaum, E.1    Levy, Y.2    Shoenfeld, Y.3
  • 31
    • 0031802363 scopus 로고    scopus 로고
    • Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy
    • Sundin U, Nava S, Hammarstrom L. Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy. Clin Exp Immunol 1998; 112: 341-346.
    • (1998) Clin. Exp. Immunol. , vol.112 , pp. 341-346
    • Sundin, U.1    Nava, S.2    Hammarstrom, L.3
  • 32
    • 0031871760 scopus 로고    scopus 로고
    • Immunoglobulin replacement treatment by rapid subcutaneous infusion
    • Gaspar J, Gerritsen B, Jones A. Immunoglobulin replacement treatment by rapid subcutaneous infusion. Arch Dis Child 1998; 79: 48-51.
    • (1998) Arch. Dis. Child. , vol.79 , pp. 48-51
    • Gaspar, J.1    Gerritsen, B.2    Jones, A.3
  • 33
    • 0033982566 scopus 로고    scopus 로고
    • Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: Case report and literature review of intravenous immunoglobulin-related thrombotic complications
    • Go RS, Call TG. Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: Case report and literature review of intravenous immunoglobulin-related thrombotic complications. Mayo Clin Proc 2000; 75: 83-85.
    • (2000) Mayo Clin. Proc. , vol.75 , pp. 83-85
    • Go, R.S.1    Call, T.G.2
  • 34
    • 0021259298 scopus 로고
    • Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases
    • Ochs HD, Fischer SH, Wedgwood RJ, et al. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. Am J Med 1984; 76: 78-82.
    • (1984) Am. J. Med. , vol.76 , pp. 78-82
    • Ochs, H.D.1    Fischer, S.H.2    Wedgwood, R.J.3
  • 35
    • 0035822661 scopus 로고    scopus 로고
    • The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia: A randomized, double-blind, multicenter crossover trial
    • for the Inter-University Working Party for the Study of Immune Deficiencies
    • Eijkhout HW, van der Meer JWM, Kallenberg CGM, et al., for the Inter-University Working Party for the Study of Immune Deficiencies. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia: A randomized, double-blind, multicenter crossover trial. Ann Intern Med 2001; 135: 165-174.
    • (2001) Ann. Intern. Med. , vol.135 , pp. 165-174
    • Eijkhout, H.W.1    van der Meer, J.W.M.2    Kallenberg, C.G.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.